CTIS2023-506827-26-00进行中（未招募）1 期
ong-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS) - NN9535-4352
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,467
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Male or female, age =18 years at the time of signing informed consent, Diagnosed with type 2 diabetes mellitus., HbA1c of 7.0-10.0% (53-86 mmol/mol) (both inclusive).
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A research study to look at how semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2017-003619-20-SKovo Nordisk A/S1,400
进行中（未招募）
1 期
A research study to look at how semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2017-003619-20-PTovo Nordisk A/S1,500
进行中（未招募）
1 期
A research study to look at how semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2017-003619-20-CZovo Nordisk A/S1,500
进行中（未招募）
1 期
A research study to look at how semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2017-003619-20-GBovo Nordisk A/S1,500
进行中（未招募）
1 期
A research study to look at how semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2017-003619-20-LVovo Nordisk A/S1,500